trial
as of 2026-07-01Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia
NCTId NCT00664274
at a glance
— · Unknown
Enrollment 142 (estimated)
Sponsored by Manhattan Psychiatric Center
Primary completion 2015-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
142 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2007-04
Primary completion
2015-01
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Manhattan Psychiatric CenterLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Albert Einstein College of MedicineCollaborator
Investigators
4
Jean-Pierre Lindenmayer, M.D.Principal Investigator
Herbert Y Meltzer, M.D.Study Chair
Susan Mc Gurk, PhDStudy Chair
Anzalee Khan, PhDStudy Chair
Sites
1 total
Wards Island, United States
Facts & assertions
4 sourced
Enrollment
142
Phase
NA
Primary Completion Date
2015-01
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
indication
investigator
person
person
person